Plutux
$287.61
-1.65%
2026-09-03 14:08:30 EDT-$4.83
Healthcare
Medical - Devices
NASDAQ
Active Trading

UFP Technologies, Inc. specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams, films, ...

Price Action

$287.61
-1.65%-$4.83
High
Low
52W High-15.1%
Rel. vol
Interval
Range6.5h
VolumeSMA5SMA10
UFP Technologies is a public contract development and manufacturing company whose core value proposition is combining product design, material science, engineering, converting, assembly, and packaging in one supplier relationship. Founded in 1963 and headquartered at 100 Hale Street in Newburyport, Massachusetts, the company has evolved from a materials-focused manufacturer into ...UFP Technologies is a public contract development and manufacturing company whose core value proposition is combining product design, material science, engineering, converting, assembly, and packaging in one supplier relationship. Founded in 1963 and headquartered at 100 Hale Street in Newburyport, Massachusetts, the company has evolved from a materials-focused manufacturer into a diversified provider of highly engineered solutions, with healthcare representing its principal end market. Its medical business includes components and devices used in general medical applications, disposable wound care, infection control, minimally invasive surgery, surgical robotics, wearable technologies, orthopedic soft goods, and protective packaging for orthopedic implants. These products are often designed for single-use or single-patient applications, where consistency, cleanliness, traceability, and regulatory compliance are important purchasing criteria. The company works with advanced foams, films, plastics, natural-fiber materials, and related substrates. Its manufacturing and engineering activities can include material selection, prototyping, design-for-manufacturability, die cutting, laminating, thermoforming, molding, assembly, welding, packaging, and other custom-conversion processes. The bill of materials for a particular product is therefore customer-specific, but may include polymer films, engineered foams, adhesives, molded plastic parts, textiles, release liners, packaging materials, and purchased or internally assembled components. UFP Technologies generally competes through technical expertise, quality systems, production reliability, and the ability to support customers from concept development through commercialization rather than by selling a standardized catalog product. Outside healthcare, its engineered products and components are used in military uniforms and gear, automotive interior trim, athletic padding, sustainable protective packaging, air-filtration products, abrasive nail files, and custom protective cases and inserts. Sales are primarily conducted in the United States through a direct sales force supported by independent manufacturer representatives, while the company maintains a broader operational footprint associated with its international and multi-site manufacturing activities. Based on the supplied trailing-twelve-month data, UFP Technologies had approximately $2.43 billion in market capitalization, a 28.5% gross margin, a 15.3% EBIT margin, an 18.3% EBITDA margin, and an 11.4% net margin. Its current ratio was approximately 3.0, debt-to-equity was 0.254, and interest coverage was about 12.4 times, indicating comparatively moderate leverage and solid reported coverage. The company generated approximately $67.8 million of free cash flow to the firm and $35.4 million of free cash flow to equity in the supplied period. The reported price-to-earnings ratio was approximately 33.5 and the company paid no dividend in the supplied data. Mitchell C. Rock is identified as chief executive officer, while supplied management references also identify R. Jeffrey Bailly as chairman and Ronald J. Lataille as senior vice president, treasurer, and chief financial officer. Key business considerations include medical-device customer concentration, regulatory and quality requirements, material and labor costs, integration of acquisitions or manufacturing sites, inventory management, and the need to continually invest in efficient production capacity and product-development capabilities.
Founded
1963
Employees
4846
CEO
Mitchell C. Rock
Full Name
UFP Technologies, Inc.
Sector
Healthcare
Industry
Medical - Devices
ROE
16.72%
Market Cap
$2.23B
Current Ratio
3.00
WACC
9.22%
ROIC
13.91%

Contact Information

978 352 2200
100 Hale Street, Newburyport, MA 01950-3504

Related stocksMedical - Devices

Browse all US stocks

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026